JT
Juvena Therapeutics, Inc.
SEC filingOther Technology · Redwood City, CA
Amount raised$30.5Msold at filing
Total offering$41M$10.5M still open
Investors in the raise12count reported to the SEC
FiledJul 25, 2025first sale Jun 27, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Steven JamesDirector
Ben HemaniDirector
Stephen JuelsgaardDirector
Hanadie YousefExecutive Officer, Director
Laura Lande-DinerDirector
Christopher KirkDirector
Ayman AlAbdallahDirector
Jeremy O'ConnellDirector
Executive officers, directors and promoters as listed on the Form D.